1. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial [published correction appears in Lancet. 2019 Jul 6;394(10192):e1]. Lancet. 2019;393(10180):1505–1516. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495367/?report=reader2. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130(4):429–440.3. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–830. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/270953.4. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–830. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2709295. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol. 1995;120(6):718–731. https://www.ajo.com/article/S0002-9394(14)72725-4/pdf6. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–1953. https://www.aaojournal.org/article/S0161-6420(01)00873-9/pdf7. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2722588. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group [published correction appears in Am J Ophthalmol 1999 Jan;127(1):120]. Am J Ophthalmol. 1998;126(4):487–497. https://www.ajo.com/article/S0002-9394(98)00223-2/pdf 9. Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R; CIGTS Study Group. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118(9):1766–1773. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161134/ 10. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047148/pdf/bjophthalmol-2017-310902.pdf